Drugs in Dev.
Infections and Infectious Diseases
Discovery
China 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : BAT2022,VHH18. 2F8
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Bio-Thera Solutions Reported the Discovery of a SARS-CoV-2 Neutralizing Antibody
Details : BAT2022 demonstrated potent in vivo efficacy against SARS-CoV-2 in a mice model both prophylactically and therapeutically, protecting animals from disease progress and abolishing virus replication in the lungs.
Product Name : Undisclosed
Product Type : Antibody, Unconjugated
Upfront Cash : Inapplicable
August 11, 2021
Lead Product(s) : BAT2022,VHH18. 2F8
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : Evotec
Deal Size : Undisclosed
Deal Type : Collaboration
HitGen and Evotec SE Enter Into Drug Discovery Research Collaboration
Details : HitGen will apply its platform technology, based on the design, synthesis and screening of DNA-encoded libraries (DEL) to identify small molecule leads against targets of interest to Evotec SE in the field of anti-infectives.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 08, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : Evotec
Deal Size : Undisclosed
Deal Type : Collaboration
